TTD | Drug: D0V1SD

Drug General Information
Drug ID	D0V1SD
Former ID	DCL000728
Drug Name	BP4.879a
Drug Type	Small molecular drug
Indication	Schizophrenia [ICD9: 295; ICD10:F20]		Terminated	[536463]
Company	Bioprojet
Structure		Download 2D MOL 3D MOL
Formula	C17H22N4O
Canonical SMILES	CN1C2CCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
InChI	1S/C17H22N4O/c1-20-12-7-8-13(20)10-11(9-12)18-17(22)16-14-5-3-4-6-15(14)21(2)19-16/h3-6,11-13H,7-10H2,1-2H3,(H,18,22)/t11?,12-,13+
InChIKey	DDHAJFBBJWHSBR-YHWZYXNKSA-N
PubChem Compound ID	5311254
PubChem Substance ID	7979819, 11111356, 14825168, 15843773, 39340958, 47586782, 49982467, 57359405, 75446884, 114155673, 134339226, 134340195, 174520197, 178100910, 179235835, 242129848
Target and Pathway
Target(s)	D(3) dopamine receptor	Target Info	Antagonist	[536463]
KEGG Pathway	Neuroactive ligand-receptor interaction
KEGG Pathway	Dopaminergic synapse
Reactome	Dopamine receptors
Reactome	G alpha (i) signalling events
WikiPathways	Monoamine GPCRs
	GPCRs, Class A Rhodopsin-like
	GPCR ligand binding
	GPCR downstream signaling
	Nicotine Activity on Dopaminergic Neurons
	GPCRs, Other
References
Ref 536463	The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. Epub 2007 Jul 31.
Ref 536463	The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. Epub 2007 Jul 31.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information